Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | BMY | GSK | ||
| Company | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 454.50 | 59.21 | 51.72 | ||
| High | 459.45 | 59.64 | 52.69 | ||
| Low | 449.75 | 58.09 | 51.65 | ||
| Latest | 458.05 | 58.11 | 52.37 | ||
| Change | +6.46 | -1.26 | +0.31 | ||
| % Change | +1.43% | -2.12% | +0.60% | ||
| Volume | 1,299,143 | 12,443,801 | 3,967,261 | ||
| 20-Day Average Volume | 1,394,497 | 12,354,145 | 5,176,468 | ||
| Previous Close | 451.59 | 59.37 | 52.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 474.96 | 60.54 | 56.09 | ||
| 20-Day Raw Stochastic | 14.27% | 0.42% | 8.57% | ||
| 20-Day Relative Strength | 46.55 | 46.57 | 41.19 | ||
| Weighted Alpha | -3.30 | +6.34 | +35.78 | ||
| Today's Opinion | 64% Buy | 56% Buy | 56% Buy | ||
| Previous Opinion | 48% Buy | 80% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.20% since 03/12/26 | -1.42% since 03/12/26 | -3.52% since 03/12/26 | ||
| Low | 449.75 on 03/19/26 | 58.09 on 03/19/26 | 51.65 on 03/19/26 | ||
| High | 486.66 on 03/13/26 | 60.81 on 03/17/26 | 54.73 on 03/13/26 | ||
| 1-Month | |||||
| %Chg | -2.39% since 02/19/26 | -3.63% since 02/19/26 | -13.94% since 02/19/26 | ||
| Low | 449.75 on 03/19/26 | 58.09 on 03/19/26 | 51.65 on 03/19/26 | ||
| High | 507.92 on 03/10/26 | 62.89 on 03/02/26 | 60.05 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | +0.41% since 12/19/25 | +7.23% since 12/19/25 | +7.74% since 12/19/25 | ||
| Low | 429.00 on 01/20/26 | 52.06 on 01/05/26 | 47.62 on 01/20/26 | ||
| High | 507.92 on 03/10/26 | 62.89 on 03/02/26 | 61.69 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | +19.56% since 09/19/25 | +29.08% since 09/19/25 | +28.77% since 09/19/25 | ||
| Low | 374.17 on 09/24/25 | 42.52 on 10/29/25 | 39.29 on 09/25/25 | ||
| High | 507.92 on 03/10/26 | 62.89 on 03/02/26 | 61.69 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 114,719,208 | 120,905,456 | 106,100,472 | ||
| Shares Outstanding, K | 254,034 | 2,036,474 | 2,038,042 | ||
| Annual Sales | 12,001,300,000 | 48,194,000,000 | 43,077,970,000 | ||
| Annual Net Income | 3,953,200,000 | 7,054,000,000 | 7,537,690,000 | ||
| Last Quarter Sales | 3,190,000,000 | 12,502,000,000 | 11,424,970,000 | ||
| Last Quarter Net Income | 1,191,100,000 | 1,086,000,000 | 851,670,000 | ||
| 60-Month Beta | 0.31 | 0.26 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.03 on 02/12/26 | 1.26 on 02/05/26 | 0.68 on 02/04/26 | ||
| Latest Earnings Date | 05/04/26 | 04/23/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | 0.630 on 01/02/26 | 0.478 on 02/20/26 | ||
| Next Ex-Dividends Date | N/A | 04/02/26 | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 28.17 | 9.71 | 11.82 | ||